BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin RX, Yang SL, Jia Y, Wu JC, Xu Z, Zhang H. Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs. Semin Cancer Biol 2021:S1044-579X(21)00077-8. [PMID: 33785446 DOI: 10.1016/j.semcancer.2021.03.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad A. Special Issue: Epigenetic regulation of cancer progression: Promises and progress. Semin Cancer Biol 2021:S1044-579X(21)00298-4. [PMID: 34921992 DOI: 10.1016/j.semcancer.2021.12.005] [Reference Citation Analysis]
2 Zhang Y, Lu K, Ding J, Peng Y, Pan G, Teng L, Luo D. Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto’s Thyroiditis. Front Oncol 2022;12:766016. [DOI: 10.3389/fonc.2022.766016] [Reference Citation Analysis]
3 Song J, Sun Y, Cao H, Liu Z, Xi L, Dong C, Yang R, Shi Y. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma. Bioengineered 2021;12:5932-49. [PMID: 34488540 DOI: 10.1080/21655979.2021.1972078] [Reference Citation Analysis]
4 Zeng L, Yuan S, Zhou P, Gong J, Kong X, Wu M. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression. Bioengineered 2021;12:11795-810. [PMID: 34927541 DOI: 10.1080/21655979.2021.2008639] [Reference Citation Analysis]
5 Zheng J, Wang X, Shi J, Tian J, Chang X, Wang X, Ye Q, Tu W. Expression and Clinical Significance of lncRNA NEAT1 in Patients with Spinal Tuberculosis. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/5748756] [Reference Citation Analysis]